EFU ETF Research - ProShares UltraShort MSCI EAFE

ProShares UltraShort MSCI EAFE (efu)

Last Updated by WikiWealth | Update This Page Now

►Summary | Add New ETF | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 156

Threats + Weaknesses = 99

When strengths & opportunities substantially exceed threats & weaknesses an investment in the efu ETF has great long term potential.

ETF Description Update

ProShares UltraShort MSCI EAFE (EFU) Description: EFU is an exchange trading fund (ETF), which is a security that tracks a basket of assets, but trades like a stock. EFU exchange trading fund (ETF) tracks the MSCI EAFE (-200%); proshares ultrashort msci eafe seeks daily investment results that correspond to twice (200%) the inverse (opposite) of the daily performance of the msci eafe index. ProShares UltraShort MSCI EAFE (EFU) falls under the Leveraged Equities category. EFU's dividend yield is roughly 0%, it has an expense ratio of 0.95%, and is in the equity ETF asset class. ProShares UltraShort MSCI EAFE (EFU) focuses its investments in the Euro-Pacific region of the world. EFU has an ETF leverage of two times (2x) and the performance of the EFU ETF is inversely-related to its benchmark; in other words, EFU is short the index. The EFU ETF is not affiliated with a particular ETF sector. An investor can find EFU's top holdings, fundamental analysis, and fund ratings on the left side of the screen. The right side features EFU's technical analysis chart and long term fund potential. Long term and short term buy ratings indicate our highest possible valuation rating. Click here for additional information on ProShares ETF funds or see the ETF research & analysis home page to start.

Portfolio Strategy Update

Be the first to explain ProShares UltraShort MSCI EAFE (EFU)'s strategy.

Performance Analysis Update